期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 120, 期 1, 页码 223-241出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI38012
关键词
-
资金
- China National Key Projects for Infectious Disease [2008ZX10002-021, 2008ZX10002-020]
- Chinese National Key Program on Basic Research [2010CB529200, 2006CB910402]
- International Scientific Collaborative Project [20072901]
- Shanghai Commission for Science and Technology [08JC1416400, 06ZR14069, 06DZ22903]
- China Postdoctoral Science Foundation [20070420097]
- Shanghai Postdoctoral Science Foundation [07R214138]
The epigenetic silencing of tumor suppressor genes is a crucial event during carcinogenesis and metastasis. Here, in a human genome-wide survey, we identified scavenger receptor class A, member 5 (SCARA5) as a candidate tumor suppressor gene located on chromosome 8p. We found that SCARA5 expression was frequently downregulated as a result of promoter hypermethylation and allelic imbalance and was associated with vascular invasion in human hepatocellular carcinoma (HCC). Furthermore, SCARA5 knockdown via RNAi markedly enhanced HCC cell growth in vitro, colony formation in soft agar, and invasiveness, tumorigenicity, and lung metastasis in vivo. By contrast, SCARA5 overexpression suppressed these malignant behaviors. Interestingly, SCARA5 was found to physically associate with focal adhesion kinase (FAK) and inhibit the tyrosine phosphorylation cascade of the FAK-Src-Cas signaling pathway. Conversely, silencing SCARA5 stimulated the signaling pathway via increased phosphorylation of certain tyrosine residues of FAK, Src, and p130Cas; it was also associated with activation of MMP9, a tumor metastasis-associated enzyme. Taken together, these data suggest that the plasma membrane protein SCARA5 can contribute to HCC tumorigenesis and metastasis via activation of the FAK signaling pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据